A dosimetry system using lithium formate monohydrate ͑HCO 2 Li· H 2 O͒ as detector material and electron paramagnetic resonance ͑EPR͒ spectroscopy for readout has been used to measure absorbed dose distributions around clinical 192 Ir sources. Cylindrical tablets with diameter of 4.5 mm, height of 4.8 mm, and density of 1.26 g / cm 3 were manufactured. Homogeneity test and calibration of the dosimeters were performed in a 6 MV photon beam.
I. INTRODUCTION

Interest in experimental 192
Ir dosimetry has increased and recent applications include the development of detectors suitable for in vivo dosimetry 1 and for verifying the doses calculated by treatment planning systems ͑TPSs͒.
2 Dose calculation in treatment planning of brachytherapy is based on the superposition of precalculated single-source dose distributions in water 3 which is why the distributions must be well characterized before a new 192 Ir source model can be clinically used. To this end, the American Association of Physicists in Medicine ͑AAPM͒ recommends use of the brachytherapy dose calculation formalism presented in Task Group 43 ͑TG43U1͒ report. 3 This is primarily concerned with lowenergy seeds and, for these, both an experimental and a Monte Carlo study for each new type of source should be performed. For new sources of the more energetic 192 Ir isotope, either an experimental or a Monte Carlo ͑MC͒ characterization is recommended. 4 Dose gradients around 192 Ir brachytherapy sources are steep and small dosimeters are needed to resolve them. In addition, the photon energy spectrum varies significantly with depth so that dosimeters with a low-energy dependence relative to water ͑the reference medium for brachytherapy dosimetry͒ are desirable. Furthermore, the dosimeters should be able to respond linearly over a large range of absorbed dose and dose rate values. The most common dosimetry system for brachytherapy uses thermoluminescent ͑TL͒ dosimeters of lithium fluoride ͑LiF͒. [5] [6] [7] However, while such dosimeters can be made small enough for resolving steep dose gradients, they have several drawbacks. Their energy dependence relative to water is relatively strong, the dose range within which the response is linear is fairly small, and they may exhibit a LET dependence. 8, 9 For low-energy ͑Ͻ50 keV͒ photon-emitting single brachytherapy sources, the combined relative standard uncertainty in experimental data is typically about 8%, 3 while for 192 Ir the corresponding figure is 6%-7%. 10 Alanine, the most common material in electron paramagnetic resonance ͑EPR͒ dosimetry, has been used for measurements around 192 Ir brachytherapy sources. [11] [12] [13] A drawback of EPR dosimetry is the need for high doses ͑above around 1-2 Gy͒ while an advantage is the system's linear response over a large dose interval 14 making it easy to measure doses around pulsed dose rate ͑PDR͒ and high dose rate ͑HDR͒
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Ir sources at their clinical strength. The verification of doses at several distances from an implant with a single ir-radiation will not be a problem and doses large enough for the source transit dose [15] [16] [17] to be negligible can easily be administered. Due to problems with supralinearity, TL dosimeters close to the source must often be withdrawn before ones at larger distances. Early reports on TL dosimetry for 192 Ir was for low dose rate ͑LDR͒ seeds 7 and TL dosimetry around 192 Ir HDR and PDR sources is mostly made with decayed sources. 10, 18 In experimental verifications of treatment plans, it is not possible to perform corrections due to changes in photonenergy spectra since these are unknown for an arbitrary multiple-source implant. It is thus of interest to have access to a dosimetry system with little dependence on energy. Lithium formate monohydrate is currently one of the most promising materials for EPR dosimetry. Depending on readout procedure, lithium formate is two to six times more sensitive 19, 20 than alanine. Furthermore, at energies below 200 keV the energy absorption characteristics of lithium formate are more similar to water than those of alanine and LiF. Figure 1 presents the mass-energy absorption coefficients of water relative to LiF, alanine, and lithium formate for monoenergetic photons. As can be seen, the ratio varies substantially less at low energies for lithium formate than for the other detector materials.
The radiation induced radicals in lithium formate are well characterized, 21 the dose response was found to be linear over a large dose range ͑0.2-1000 Gy͒, 20 and no signal fading was observed for at least 28 days. 19 Lithium formate EPR dosimetry has been compared with LiF TL dosimetry 22 and been used, for example, in measurements in high-energy electron beams. 23 Gustafsson et al. 24 recently applied lithium formate dosimeters to verify planned IMRT doses.
The aim of the present work was to evaluate the performance of a lithium formate monohydrate EPR dosimetry system 19, 24 ͑from now on called the lithium formate dosimetry system͒ for measurements around 192 Ir brachytherapy sources.
II. MATERIALS AND METHODS
II.A. The lithium formate dosimetry system
The lithium formate dosimetry system summarized below is the same system as that used earlier to verify planned IMRT doses. 24 More details about this system are reported elsewhere. 19 This section starts by describing how dosimeters were manufactured ͑Sec. II A 1͒, continues with details of the EPR read-out procedure ͑Sec. II A 2͒ and the doseresponse homogeneity test that all dosimeters underwent ͑Sec. II A 3͒, and ends by describing how the system was calibrated for absolute dose measurements ͑Sec. II A 4͒.
II.A.1. Dosimeter manufacture
The active dosimetry material "lithium formate monohydrate" ͑HCO 2 Li· H 2 O͒ was purchased from Aldrich. Solid household paraffin ͑Haugen-Gruppen AB, Norrköping, Sweden͒ was used as a binder ͑10% of dosimeter weight͒.
Lithium formate was crushed in a mortar. The crushed material was sieved to the grain size interval 180 m Ͻ d Ͻ 500 m using an Endecotts MINOR test sieve shaker and was put in a beaker together with solid paraffin. The beaker and its content were heated in an oven until the paraffin had melted. Since paraffin has a lower melting point ͑54-56°C͒ than lithium formate crystals ͑94°C͒, it melts without damaging the grains. The two components were mixed thoroughly. Heating and mixing were repeated twice. Using a manual pellet press, cylindrical dosimeters of diameter 4.5 mm and height 4.8 mm were prepared from 100 mg of the mixture. Tablets outside the mass interval 100Ϯ 1 mg were rejected. Dosimeters made from the same mixture were regarded as belonging to one batch and used together in the subsequent experiments. All dosimeters were stored in the same environmental conditions.
II.A.2. EPR readout
The dosimeter signal was measured using a BRUKER EleXsys E580 EPR spectrometer equipped with a standard cavity ER 4102ST. Tablets were held in a WILMAD EPR sample tube, Q-5M-6M-0-200m-FB ͑inner diameter of 5 mm, flat bottom͒, resting in the notch of an in-cavity pedestal which ensured that the tube was placed in the same position in each reading. Spectrometer settings were chosen in order to optimize the precision of repeated measurements of a single dosimeter within a reasonable time interval. As described previously 19, 24 the highest precision was achieved for measurements with a narrow sweep width ͑3 mT͒ without using an in-cavity reference such as synthetic ruby or Mn2 + / MgO. The readings were thus performed using an applied microwave power of 20 mW, 3 mT sweep width, 1.2 mT modulation amplitude, 328 ms time constant, and one 168 s sweep. The EPR signal was not smoothed, filtered, or manipulated in any way. The signal amplitude was determined as the peak-to-peak height in the first derivative of the absorbance spectrum ͑l͒ divided by the mass w of the dosimeter and was denoted l w ͑mg −1 ͒. The signal amplitude for each dosimeter was defined as the average of five measurements. The sensitivity of the spectrometer varies from day to day. For this reason, all dosimeters in a batch were measured during the same day in one measurement session. In order to compensate for possible small variations in spectrometer sensitivity during a measurement session, the five readings of each dosimeter were spread out during the day. It is well known that nonirradiated alanine EPR dosimeters, to various degrees, have a zero-dose signal due to mechanically induced radicals. 25 However, no mechanically induced signal was observed in nonirradiated lithium formate tablets. This is in accordance with findings by Vestad et al. 20 
II.A.3. Dose-response homogeneity control
By using the manufacturing method described above, all dosimeters of one batch will have the same dose response ͑signal per unit absorbed dose͒ to within a certain spread depending partly on dosimeter properties such as size, density, and binder distribution and partly on spectrometer sensitivity variations. By irradiating all dosimeters to the same dose, this spread can be determined in terms of the relative standard deviation in resulting signals of one batch. All dosimeters of a batch ͑ten at a time for batches of 30 dosimeters͒ were irradiated to the same dose ͑at least 3 Gy͒ in a 6 MV photon beam ͑Varian Clinic 600 C/D accelerator͒ at 5 cm depth in a PMMA phantom using a field of area 15 ϫ 15 cm 2 and SSD 100 cm. The sides of the PMMA phantom were 20ϫ 20 cm 2 , the height was 6 cm, and 8 cm backscattering material ͑PMMA͒ was employed. To remove any influence of the slightly nonhomogeneous beam profiles ͑i.e., to ensure the same dose to each dosimeter independent of position within the beam͒ the dosimeters were rotated in the phantom so that each one was irradiated for the same time in each position. In the present work, the relative standard deviation of the signals of one whole batch, consisting of 30 dosimeters, was 0.6%. The signal corresponding to the absorbed dose in the homogeneity control irradiation is from now on regarded as the ͑induced͒ background signal.
II.A.4. Calibration of the dosimeters
In order to be able to use the EPR dosimeter signal to measure absorbed dose to water during irradiation with the 192 Ir source, the signal per mean absorbed dose in the dosimeter, D det , needs to be known ͑see Sec. III A͒. To achieve this, the dose response of the dosimeters in terms of absorbed dose to water was first determined using a beam quality at which absolute dosimetry is feasible. A subset of the batch ͑five dosimeters͒ was thereby irradiated in a clinical 6 MV photon beam in the same PMMA phantom as used in the dose-response homogeneity control ͑Sec. II A 3͒ but now at 8.4 cm depth in a 10ϫ 10 cm 2 field at SSD of 100 cm. An ion chamber ͑Farmer NE 2571͒, with a 60 Co absorbed dose to water calibration factor traceable to the Swedish Secondary Standards Dosimetry Laboratory, was irradiated simultaneously at the same depth as the dosimeters. The absorbed dose to water was estimated following the IAEA protocol 26 using beam quality correction factors valid for the 6 MV photon beam under reference conditions in a water phantom ͑10ϫ 10 cm 2 field, SSD of 100 cm, and 10 cm depth͒. The irradiation setup used here closely matches that recommended for absolute dosimetry using plastic phantoms. 27 From Seuntjens et al., 27 it is clear that the nonreference conditions obtained by using a PMMA phantom instead of the reference water phantom introduces a small error in perturbation correction factors ͑see Table III in the cited reference͒ which is accounted for in the uncertainty analysis ͑Sec. III C 1͒. The homogeneity of the beam for the 10ϫ 10 cm 2 field at the calibration depth was determined using diodes to be within 0.3%. The calibration curve is described by
where l w is the signal ͑mg −1 ͒, a ͑mg −1 Gy −1 ͒ the slope of the curve, b its intercept with the signal axis, and D the absorbed dose to water. Since all dosimeters of a batch already had obtained a dose ͑in the dose-response homogeneity control, Sec. II A 3͒ and since the corresponding signal is not erased during readout, the intercept with the signal axis will be nonzero. The calibration curve is determined by using a subset of five dosimeters as reference dosimeters, whose signals represent the background signal of the batch. The parameters of the calibration curve were calculated using the weighted least-squares matrix method 28 by fitting a straight line to the ͑dose, signal͒ points given by the two sets of reference dosimeters. Since all dosimeters of a batch have been shown to have the same dose response in the homogeneity control ͑Sec. II A 3͒, the resulting curve is taken to be representative for the whole batch. To avoid differences in signal fading, humidity, etc., all dosimeters of a batch are read out during one and the same day. As recommended by Nagy, 29 the dose administered to the ion chamber calibrated dosimeters was chosen to encompass the dose range given with the Ir irradiation was 1-3 days. The storage time between irradiation and EPR read out was well within the 28 days for which no signal fading has been observed. 19 Thus, potential, as yet undetected, signal fading would not introduce additional uncertainties in a time span relevant for clinical dosimetry.
II.B. Experimental setup for measurements in the 192
Ir beam
The PMMA phantom used consisted of eight rectangular slabs ͑with a cross-sectional area 20ϫ 20 cm 2 to a total height of 18 cm͒ with a central hole to accommodate a catheter with the 192 Ir source ͑Fig. 2, left͒. Slab number 5 contained 12 extra holes to house dosimeters ͑Fig. 2, right͒. The centers of the dosimeters were thus 8.75 cm from the phantom bottom. Dosimeters were positioned 1, 3, and 5 cm perpendicularly out from the central hole ͑see Fig. 2͒ . To minimize effects of an eventual deviation of the source position from the center in the catheter during the irradiation, the mean value of the readings of the four dosimeters at each distance was used.
Three experiments were conducted. The first was performed with a GammaMed Plus HDR source model, the second was a repetition of the first using the same afterloading unit but performed after a source exchange and thus for another source, while the third was carried out with a microSelectron-v1 PDR source.
To reduce the steepness of the dose gradients in the radial and longitudinal directions, a linear irradiation pattern accomplished by stepping the source was used. The source was stepped over a total length of 7 cm obtained in 0.5 cm steps, with the dwelling time at each position optimized ͑by the TPSs͒ to produce an as homogeneous dose distribution as possible in the longitudinal direction ͑coinciding with the direction of the 192 Ir source channel and the axial direction of the dosimeters͒. In the two HDR experiments, all dosimeters were irradiated in one run, resulting in different absorbed doses to the dosimeters depending on distance from the source. The PDR experiment was designed to give approximately the same dose to the dosimeters at all distances. Irradiation was therefore performed in three consecutive runs, in the intervals between which the inner dosimeters ͑first those at 1 cm and thereafter those at 3 cm͒ were removed from the phantom and replaced by lithium formate dummies.
For later comparisons with the experimental results, values of absorbed dose to water at 1, 3, and 5 cm were calculated using the Brachyvision ͑Varian Medical Systems Inc., Palo Alto, CA͒ TPS for the HDR experiments and with the Plato TPS ͑Nucletron BV, Veenendaal, The Netherlands͒ for the PDR experiment. The values obtained using these planning systems are based on precalculated single-source data, originally derived by Monte Carlo simulations in a cylindrical water phantom of diameter and height 40 cm in the case of the GammaMed Plus HDR source 30 and in a spherical water phantom of radius 15 cm in the case of the microSelectron-v1 PDR source.
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III. CALCULATIONS TO CONVERT MEASURED SIGNALS IN THE Ir BEAM TO ABSORBED DOSE TO WATER IN WATER PHANTOMS USED BY TPS
In Sec. III A, we describe the theory leading to an expression ͓Eq. ͑10͔͒ used to convert measured signals to absorbed dose to water in a water phantom of the size and shape used by the TPS. In Sec. III B, we derive values for the conversion and correction factors defined in Sec. III A. In Sec. III C, an uncertainty budget is made.
III.A. Theory
The signal M per unit absorbed dose in the dosimeter, D det , can be derived from the absorbed dose to water calibration in the 6 MV photon beam using the identity
Here, M denotes the net signal l w − b ͑see Sec. II A 4͒ and D w the absorbed dose to water at the position of the detector ͑dosimeter͒ at calibration. With the assumption that the signal per unit absorbed dose in the detector is the same independent of beam quality, i.e., that
the absorbed dose to water at a point r in the PMMA phantom, D w,phan ͑r͒, when irradiated in the Ir beam can be determined from
If the dosimeter is positioned with its center at r, the last factor on the right hand side of Eq. ͑4͒ can be evaluated from
Here, ⌿͑h , r͒ phan · d͑hv͒ is the energy fluence of photons with energies in the interval hv, hv + d͑hv͒ at point r in the undisturbed phantom, ͓͑ en / ͒͑h , r͔͒ i the corresponding mass-energy absorption coefficients for i = water and detector material, ͓͑ en / ͒͑r͔͒ det w the quotient of an energy fluence weighted average of the mass-energy absorption coefficients for the energy spectrum at r, and f vol ͑r͒ a correction factor for volume averaging taking into account the finite size of the detector. From Eq. ͑5͒, f vol ͑r͒ is defined by 
In measurements with an Ir source, the detector approximates one in which charged particle equilibrium ͑CPE͒ is established. Hence, the absorbed dose equals the collision kerma for the detector material, a fact utilized in deriving Eq. ͑5͒ above. In the calibration with 6 MV roentgen radiation, CPE does not exist in the detector. The Burlin theory can be applied to derive D det for use in calculating the value of M / D det .
Since the dosimeters were positioned in a PMMA phantom when irradiated in the 6 MV calibration beam, the Burlin cavity theory conversion coefficient f B = D det / D med has to be evaluated with PMMA as the medium surrounding the detector. The calibration with the ion chamber gives the absorbed dose to water in a small Bragg-Gray cavity in the PMMA phantom. This can be converted to absorbed dose to PMMA by multiplying the calibration coefficient with the mass collision stopping power ratio PMMA/water,
Finally, combining Eqs. ͑3͒, ͑4͒, ͑5͒, and ͑7͒ we get
where D w / M is given by the inverse 1 / a of the slope a of the calibration curve ͓Eq. ͑1͔͒.
In our experiments, the points r are defined by the radial distance r from the center of the phantom ͑see Fig. 2͒ . In order to compare the measured absorbed doses as determined using Eq. ͑8͒ with those derived by the TPS, two further corrections have to be applied. These are as follows ͑1͒ A correction to account for possible deviations of the source position from the center of the phantom during the irradiation has to be applied. It was assumed that this could be achieved by taking the mean M Ir of the signals of four dosimeters positioned at equal distance around the center of the phantom ͑see Fig. 2͒ . ͑2͒ The absorbed dose to water in the PMMA phantom, D w,phan ͑r͒, has to be converted to absorbed dose to water in a water phantom D w,w ͑r͒ of the same size and shape as those used by the TPS.
The absorbed dose to water, D w,w ͑r͒, which is to be compared to the absorbed dose to water calculated by the TPS, is then obtained from
Here D w,phan ͑r͒ is the absorbed dose to water in the PMMA phantom when the source is correctly positioned with its center at the center of the phantom and D w,phan ͑r͒ the absorbed dose derived from Eq. ͑8͒ using the mean M Ir ͑r͒ of the signals from four dosimeters. It is assumed that the factor D w,phan ͑r͒ / D w,phan ͑r͒ equals 1, i.e., that by taking the mean of the four dosimeter signals, the correct value for D w,phan ͑r͒ is obtained. The uncertainty introduced by this assumption is estimated in the uncertainty analysis ͓see Eq. ͑19͒ in Sec. III C 1͔. The factor f phan ͑r͒ converts absorbed dose to water measured in the experimental phantom, D w,phan ͑r͒, to absorbed dose to water in a water phantom of the size and shape used by the TPS, D w,w ͑r͒, and is given by
The absorbed dose to water, D w,w ͑r͒, in a water phantom of the size and shape used by the TPS is finally obtained from ͓with D w,phan ͑r͒ / D w,phan ͑r͒ = 1 as discussed above͔
͑11͒
Values for the conversion and correction factors were calculated for r = 1, 3, and 5 cm as described below.
III.B. Calculation of correction and conversion factors
III.B.1. Burlin cavity theory conversion factor f B
The Burlin theory treats the case of a detector positioned with its center at a point P inside an irradiated medium in
The weighting factor d is given by
Both the weighting factor d and the quotient of the massenergy absorption coefficients depend on photon energy. The conversion factor f B averaged over the photon energy spectrum is obtained from
Here,
where ⌿͑h , P͒ med · d͑h͒ is the energy fluence of photons with energies in the interval h, h + d͑h͒ at point P in the medium and D med ͑P͒ = ͐D͑h , P͒ med · d͑h͒. The conversion coefficient f B was calculated using photon and electron energy spectra simulated with the EGSnrc ͑Ref. 33͒ user code FLURZnrc ͑Ref. 34͒ to calculate appropriately averaged values of the ratios of mass collision stopping powers, ͓ m s col ͔ PMMA lithium formate , and mass-energy absorption coefficients, ͓ en / ͔ PMMA lithium formate . In the simulations, a circular photon beam of diameter of 10 cm was incident on a PMMA phantom of similar size ͑diameter of 20 cm and height of 14 cm͒ to that used in the calibration ͑Sec. II A 4͒ and energy spectra at 8.4 cm depth ͑SSD of 100 cm͒ were derived. The incident beam was simulated using a 6 MV accelerator spectrum from Mohan et al., 35 supplied with the EGSnrc distribution. Values of mass stopping powers and mass-energy absorption coefficients were taken from NIST. 36, 37 A value of the factor ͑ m s col ͒ w PMMA in Eqs. ͑7͒ and ͑8͒ was calculated using the same Monte Carlo simulated electron energy spectrum as in calculating ͓ m s col ͔ PMMA lithium formate . The numerical value of ͑ m s col ͒ w PMMA · f B was determined to be 0.9240.
III.B.2. Conversion factor † en / ‡ det w and correction factor f phan
The factors ͓ en / ͔ det w of Eqs. ͑5͒ and ͑8͒ and f phan defined in Eq. ͑10͒ and used in Eq. ͑11͒ were obtained as described below based on results of EGSnrc Monte Carlo simulations to derive photon energy fluence spectra and values of absorbed dose with the usercodes FLURZnrc ͑Ref. 34͒ and DOSRZnrc. 34 A cylindrical PMMA phantom of diameter and height 20 cm represented the experimental phantom, a cylindrical water phantom of diameter and height 40 cm the doses used in TPS data for the HDR source, and a cylindrical water phantom of diameter and height 30 cm the doses used in TPS data for the PDR source. The Monte Carlo settings were the same as in the paper ͑this issue͒ by Carlsson Tedgren and Alm Carlsson. 38 However, for this work, simulations of the 192 Ir point source emitting a photon energy spectrum for a typical, steel-encapsulated 192 Ir source 39 were performed not only with the source centrally positioned in the phantoms but also with it displaced from the center, along both the axial directions, by 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, and 3.5 cm to represent the dwelling positions. Dose values and spectra were still scored along the central radius of the phantom ͑corre-sponding to the detector positions͒. Spectra and values of absorbed doses representing the actual dwelling time sequences were derived by adding the spectra and doses for the individual dwelling positions weighted by the dwelling time in each position.
Values of ͓ en / ͔ lithium formate w were determined by averaging, over the energy fluence spectrum in the experimental phantom, water and lithium formate mass-energy absorption coefficients using data from NIST. 36 The values of ͓ en / ͔ lithium formate w were 1.0807, 1.0820, and 1.0834 at 1, 3, and 5 cm, respectively.
Values of the phantom correction factor f phan , defined in Eq. ͑10͒, are shown in Fig. 3 . Values used to correct the HDR measurements were 1.004, 1.009, and 1.034 at 1, 3, and 5 cm from the source. The corresponding values for the PDR measurements were 1.001, 1.007, and 1.021. Different correction factors are obtained due to the different sizes and shapes of the water phantoms underlying the reference data used in the TPS systems Brachyvision by Varian ͑a cylinder of diameter and height 40 cm͒ 30 and Plato by Nucletron ͑a sphere of diameter 30 cm͒. 31 Differences between phantoms of cubic and cylindrical shape are small, while they are larger for spherical phantoms. 40 Based on the results from Granero et al., 40 an additional small correction to account for the spherical shape of the water phantom underlying the Nucletron TPS data in relation to the values obtained by us in simulating cylindrical phantoms was introduced for the value of f phan at 5 cm.
III.B.3. Volume averaging correction factor f vol
The volume averaging correction factor f vol defined in Eq. ͑6͒ was calculated using known values of absorbed dose to water as a function of position as obtained from the TPS. A detailed description follows.
Consider cylindrical coordinate systems S͑O , r , , z͒ and SЈ͑OЈ , rЈ , Ј , zЈ͒, see Fig. 4 . The axes z and zЈ coincide with the source positions and the cylindrical detector axis, respectively, and are parallel to each other. The Cartesian axis xЈ is rotated so that it intersects the origin O of coordinate system S.
The coordinates ͑r , , z͒ of a point P in S are expressed via coordinates ͑rЈ , Ј , zЈ͒ in SЈ as r = r͑rЈ,Ј͒ = ͑d 2 + rЈ 2 + 2drЈ cos Ј͒ 1/2 , ͑15͒ = ͑rЈ,Ј͒, ͑16͒
follows from the cosine formula for the triangle OOЈP where cos ␣ = cos͑ − Ј͒ = −cos Ј. The explicit form of Eq. ͑16͒ will not be needed and Eq. ͑17͒ follows from Fig. 4͑b͒ . The volume averaging correction factor was calculated in the cylindrical coordinates of system SЈ as
where V = R 2 H is the volume of the cylindrical detector of height H and radius R and q͑r͒ = D͑r͒ det,phan / K c,det,phan ͑OЈ͒ gives the absorbed dose to the detector in the water phantom at a point r relative to the lithium formate collision kerma in the water phantom at the center of the detector. It was assumed that ͑i͒ the condition of CPE was fulfilled, and thus K c,det,phan ͑OЈ͒ = D͑OЈ͒ det,phan , and ͑ii͒ the setup was axially symmetric and thus the function qЈ͑r , z͒ = q͑r , , z͒ did not depend on Ј. The right hand side of Eq. ͑18͒ was calculated numerically using the adaptive integration method 41 available in the object oriented data analysis framework ROOT. 42 For a given point r, cubic splines and linear interpolations in the radial and axial directions, respectively, were used to determine the value of q͑r , z͒ from a grid of known values. An example of the dose profiles is shown in Fig. 5͑a͒ . The resulting f vol as a function of position is given in Fig. 5͑b͒ . At distances of 1, 3, and 5 cm, the values were 0.9932, 0.9992, and 0.9998. Estimates to translate the results to the case with measurements within the PMMA phantom indicate that the correction factors derived using the water phantom data will not significantly change values of f vol . 
III.C. Uncertainty budget
The uncertainties were evaluated following the "Guide to the Expression of Uncertainties in Measurements" ͑GUM͒ published by the IOS. 43 
III.C.1. Uncertainty in the experimentally determined absorbed dose
The combined relative standard uncertainty in absorbed dose, u͑D w,w ͑r͒͒ / D w,w ͑r͒, derived from the measurements using Eq. ͑11͒, was estimated by adding the uncertainties of its parameters according to the law of propagation of uncertainty. Neglecting any possible correlations between the factors in Eq. ͑11͒, we have
͑19͒
Below follows an estimation of the relative standard uncertainty ͑standard deviation͒ for each of the factors in Eq. ͑19͒. Numerical values are reported in Table III ͑Sec. IV͒. The uncertainty in a single dosimeter signal M Ir = l w − b depends on the uncertainties in both the signal l w and the background signal b. Type B uncertainties are regarded as negligible, since systematic errors were minimized in the experimental design. Efforts to reduce systematic errors include weighing of dosimeters before and after readout, spreading out the five readouts of one dosimeter during the day, storing all dosimeters under the same environmental conditions, and so on ͑Sec. II A 3͒. The uncertainty in the signal l w was taken to be the value of 0.6% ͑the standard deviation determined from the readings in the homogeneity test͒. The relative standard deviation in b is determined by the same figure; however, since b is given by the average signal of five dosimeters its uncertainty is further divided by ͱ 5.
The relative uncertainty in the inverse of the dose response u͑D w / M͒ / ͑D w / M͒ is equal to the relative uncertainty in a, which is given by the least-squares fit. It depends on the uncertainties in the absorbed doses and the corresponding signals of the points determining the calibration curve. To take into account the uncertainty for use of the ion chamber outside full reference conditions, 27 the uncertainty in the absorbed dose to water at calibration is estimated to be 1.1%, a figure that is slightly higher than the value of 0.8% estimated for the determination of absorbed dose to water at hospitals in the IAEA protocol. 26 The contribution of the covariance between a and b to the total combined relative uncertainty was found to be negligible ͑around 1% of that in the signal͒, similar to findings reported for an EPR/alanine system by Anton. 44 Values of the quotients of mass-energy absorption coefficients ͓͑ en / ͒ lithium formate w ͔ and mass collision stopping powers ͓͑ m s col ͒ w PMMA ͔ at 6 MV and in the phantom correction factor f phan are all derived using energy spectra and dose values derived in actual phantoms from Monte Carlo simulations. The uncertainties in these quantities are hence low and the relative standard deviation ͑type B estimation͒ is estimated to be 0.5%. The uncertainty in f phan at 5 cm is increased to 0.7% since corrections for phantom size and shape increase with increasing distance from the source. 38, 40 The uncertainty in the Burlin conversion coefficient f B is estimated by assuming a maximum deviation f B,max − f B,min as caused by assuming the weighting factors to be d =1 ͑the detector is a small Bragg-Gray detector͒ and d =0 ͑the detector is a "large" detector in which CPE prevails͒ at all photon energies. A triangular distribution is assumed for the type B estimation of the standard deviation.
The uncertainty in correction factor D w,phan ͑r͒ / D w,phan ͑r͒ is estimated by assuming the source dwell positions to be misaligned into positions at most 0.5 mm away from the center of the 3 mm diameter hole for the catheter and comparing the mean of the absorbed doses at the positions of the four dosimeters with the value obtained with correctly positioned source steps. The relative standard uncertainty ͑type A͒ was estimated using Monte Carlo simulation assuming a constant probability for the source to take any position within a circle of radius of 0.5 mm around the center of the phantom.
The uncertainty in the volume averaging correction factor f vol is estimated by studying the influence of the uncertainty in positioning ͑Ϯ 0.5 mm͒ of the dosimeters on this factor. The type B estimate of the standard uncertainty is derived assuming a rectangular distribution.
III.C.2. Uncertainty in the absorbed dose calculated by the TPS
The total combined relative standard uncertainty in the absorbed dose given by the TPS is estimated from
where u͑D w,MC ͒ is the uncertainty in the Monte Carlo simulation data from which the TPS dose values are derived and u͑RAKR͒ the uncertainty in the reference air kerma rate. The source certificate states that the expanded ͑coverage factor of 3͒ combined standard uncertainty in source calibration is Ϯ 5% of the reference air kerma rate, which gives a relative standard deviation of approximately 1.7%.
Granero et al. 45 evaluated the dose rate uncertainty for an 192 Ir source similar to the one used in this work following the recommendation of the TG-43U1 report 3 and including both type A and type B uncertainties. The combined relative standard deviation of 2.7% obtained by these authors is used here as an estimate of u͑D w,MC ͑r͒͒ / D w,MC ͑r͒.
IV. RESULTS
The absorbed doses to water at distance r from the center of the 192 Ir source, D w,w ͑r͒, obtained from the experiments and D w,TPS ͑r͒, given by the TPS, are listed in Table I for the two experiments with the HDR source model and in Table II  for Table III. In  Tables I and II expanded ͑coverage factor of 2͒ combined relative uncertainties representing 95% confidence intervals are indicated. These can be considered as the error limits.
The uncertainty in the measured signals M Ir depends on the background absorbed dose ͑from the homogeneity test͒ and the absorbed doses registered by the dosimeters at irradiation in the PMMA phantom. The two values given in Table III are the uncertainties in the HDR and PDR ͑HDR/ PDR͒ experiments, respectively. The corresponding background absorbed doses were 3 Gy/7 Gy. In the HDR experiments, all dosimeters were irradiated during the same session with the maximum and minimum registered absorbed doses being 25 Gy ͑at 1 cm͒ and 3 Gy ͑at 5 cm͒. In the PDR experiment, three irradiation sessions were used so as to obtain approximately the same absorbed dose in the dosimeters ͑15 Gy͒ at all distances.
The results in Tables I and II show that the experimentally determined absorbed doses to water agree well within the estimated uncertainties with the absorbed doses calculated by the TPS. The deviations range from +1.4% to Ϫ2.9% and indicate that the uncertainties have not been underestimated in our analysis.
V. DISCUSSION
The combined relative standard uncertainty in the experimentally determined absorbed doses is 1.3%-1.7% ͑see entry 10 in Table III͒ . The largest contribution comes from the spread in the dose response of the dosimeters in any one batch. The correction for the volume averaging effect is small: 0.993 at 1 cm distance and 1.000 at 5 cm from the center. This is because we used a linear pattern for stepping the source to reduce gradients in the radial and longitudinal directions. The dosimeters are larger than the LiF dosimeters normally used to verify single-source dose distributions at short distances. However, in this study, we wanted to test the feasibility of the lithium formate EPR dosimetry system for dose verification. In the next step, we will work on producing EPR dosimeters of smaller size. Using smaller sized dosimeters, the read-out process in the EPR spectrometer needs to be reoptimized. In this work, we used dosimeters for which the optimization procedure has already been worked out and tested. 19, 24 Dosimeters of smaller size will be less sensitive and therefore may need higher absorbed doses to reach the same degree of precision. This will not be a problem since the dosimeters have a linear response with respect to absorbed dose over a large dose interval ͑0.2-1000 Gy͒. 20 When used to verify absorbed doses from multiple-source implants or stepping sources, they will not meet such steep gradients as those around single sources and hence will be suitable also in their present size. In cases where it is not possible to correct for the variation in photon energy spectrum within the treatment volume, the low-energy dependence will be an advantage. In this study, the weighted mean of the ratio of mass-energy absorption coefficients ͓ en / ͔ lithium formate w , derived using the actual energy fluence spectrum in the PMMA phantom and for the dwelling time sequence used, increased by less than 0.5% between 1 and 5 cm from the source at the center of the phantom. The energy spectra used in deriving the ͓ en / ͔ lithium formate w were determined in the current experimental PMMA phantom, which is of comparatively small dimensions. In larger experimental phantoms, there will at the same linear distance from the source be a higher fluence of scattered, energy-degraded photons. 38 This affects the depth dependence of the ͓ en / ͔ det w ratio, accentuating the importance of either performing phantom ͑and possibly irradiation-pattern͒ specific corrections or selecting the detector with the lowest energy dependence.
The combined relative standard uncertainty in our experimentally determined absorbed doses is at most 4% ͑see entry 14 in Table III͒ and thus lower than the combined relative standard uncertainty in the dose rate constant of 7%-9% stated by TG-43 ͑Ref. 3͒ for the LiF TLD single-source dosimetry system. These results are not directly comparable since, in the present work, absorbed dose is not determined for single-source geometry, which is more demanding as regards the dimensions of the dosimeter and positional errors. The data in the TG-43U1 report ͑Ref. 3͒ furthermore refer to measurements with low-energy photon-emitting brachytherapy sources for which other types of corrections due to phantom materials, etc., are required. Kirov et al. 10 reported combined relative standard uncertainties of 6%-7% when measuring absorbed dose around a single HDR 192 Ir source with LiF TLD at distances of 3-10 cm from the source.
Compared to LiF TL dosimetry, an obvious advantage of the lithium formate dosimetry system is its larger dynamic range in absorbed dose. The LiF dosimeter has an upper dose limit of approximately 1 Gy after which supralinearity becomes a source of uncertainty. Early studies report results of LiF TL measurements around LDR 192 Ir sources 7 while more recent measurements around PDR and HDR sources have been made after the source has decayed to levels below those used clinically. 10 Using a lithium formate dosimetry system, measurements can be made using sources with clinically relevant activities. Another advantage with the large dynamic range in absorbed dose is the possibility to perform experimental verification of calculated doses over large distances in a single irradiation and that any undesired influence from the transit dose 12, [15] [16] [17] on experiments can be avoided simply by giving high enough doses for the transit dose to become negligible.
The results in Tables I and II show that in all the experiments the largest deviation between experimental and calculated absorbed doses is obtained at 5 cm distance from the source. This may be caused by a larger attenuation in the dosimeters as compared to that in an equal thickness of PMMA. To avoid such an effect, the position of the holes should be changed so that primary photons only pass through one dosimeter on their way through the phantom. This arrangement is usually used in measurements using TL-LiF dosimeters. The difference in density between PMMA ͑ = 1.19 g / cm 3 ͒ and that of the dosimeters ͑ = 1.26 g / cm 3 ͒ is, however, considerably smaller than that between PMMA and LiF ͑ = 2.64 g / cm 3 ͒, causing less problems with intershielding effects. Another possible reason for the larger deviation at 5 cm could be that the size and shape of the phantoms in which the phantom correction factors f phan were derived did not exactly match the actual ones. Differences between differently sized phantoms increase with increasing distance from the source.
38
VI. CONCLUSIONS
The lithium formate EPR dosimetry system investigated has shown to yield accurate results when used to determine absorbed doses around 192 Ir brachytherapy sources. Its lowenergy dependence relative to water makes it more suitable for dose verification than LiF TL dosimetry systems in clinically relevant situations ͑multisource implants and steppingsource irradiations where the photon energy spectrum in the general situation is unknown and hence cannot be corrected for͒. The wide dose-response linearity of the system is an advantage since dose distributions around PDR and HDR 192 Ir sources can be measured for sources of clinical strength and dosimeters can be irradiated at different distances from the source͑s͒ within one irradiation. Before the lithium formate EPR dosimetry system can be used for experimental verification of absorbed dose distributions around single sources or in other situations where dose gradients are steeper than in the present work, methods of producing and measuring with smaller dosimeters must be developed to keep the volume averaging correction reasonably low in situations with steep dose gradients such as those close ͑Ͻ3 cm͒ to a single source. 
ACKNOWLEDGMENTS
